Log in to search using one of your social media accounts:

 

Gilead Wins Reversal of $2.54 Bln Hepatitis C Drug Patent Verdict Gilead Wins Reversal of $2.54 Bln Hepatitis C Drug Patent Verdict
A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by rival Merck& Co Inc.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 20, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict
(Reuters) - A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by rival Merck& Co Inc. (Source: Reuters: Health)
Source: Reuters: Health - February 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes
(Boston Medical Center) According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, researchers from Boston Medical Center, Massachusetts General Hospital (MGH) and Stanford University found that this expanded screening would increase life expectancy and quality of life while remaining cost-effective. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 16, 2018 Category: Infectious Diseases Source Type: news

5-Question Quiz on HCV
It's a short quiz but it covers a broad range of knowledge about testing, treatment, and drug choices in persons with HCV infection. (Source: ConsultantLive)
Source: ConsultantLive - February 15, 2018 Category: Internal Medicine Authors: Patient Care Staff Tags: Hepatitis C Quiz Source Type: news

Notes from the Field: Underreporting of Maternal Hepatitis C Virus Infection Status and the Need for Infant Testing — Oregon, 2015
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - February 15, 2018 Category: American Health Source Type: news

National Viral Hepatitis Action Plan 2017-2020 Partner Planning Guide
A tool designed for use by individuals, groups, and organizations that are conducting strategic planning efforts for hepatitis B (HBV) and/or hepatitis C (HCV). (Source: PHPartners.org)
Source: PHPartners.org - February 14, 2018 Category: International Medicine & Public Health Source Type: news

Exclusive: Nurses set to lead ‘revolution’ in haemophilia care
Nursing is set to be at the forefront of “revolutionary” changes in haemophilia care, but the profession still carries a burden of “guilt” from the contaminated blood scandal that saw hundreds of NHS patients infected with HIV and hepatitis C, according to a leading specialist nurse. (Source: Nursing Times)
Source: Nursing Times - February 9, 2018 Category: Nursing Source Type: news

Sofosbuvir Regimens Benefit Hard to Treat Patients with Both HIV and Hepatitis C
Favorable results seen with sofosbuvir-containing regimens in these complex patients need to be tempered with the high potential for adverse drug interactions. (Source: ConsultantLive)
Source: ConsultantLive - February 9, 2018 Category: Internal Medicine Authors: Linda Peckel Tags: Hepatitis C Source Type: news

Hepatitis C: Toward New Public Health Models to Improve Detection and Treatment
A community health model based on direct treatment via primary care epxanded detection and treatment of HCV and also increased life expectancy.   (Source: ConsultantLive)
Source: ConsultantLive - February 9, 2018 Category: Internal Medicine Authors: Linda Peckel Tags: Hepatitis C Source Type: news

Compounds isolated from rattlesnake venom show activity against hepatitis C virus
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) Studies conducted by Brazilian researchers and published in PLOS ONE and Scientific Reports also found compounds derived from Brazilian plants to be promising against hepatitis C. In spite of the virus' resistance, tests yielded a sharp decline in viral activities such as reproduction and cell invasion. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 8, 2018 Category: International Medicine & Public Health Source Type: news

Gilead Sciences: Investors Are Betting On A Better 2019
Shares of Gilead Sciences are on the rise, even after the drug maker issued low 2018 sales projections for its hepatitis C franchise. The Street sees better times ahead. Here's why. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 7, 2018 Category: Pharmaceuticals Authors: Johanna Bennett, Contributor Tags: NASDAQ:GILD Source Type: news

Medical News Today: Diagnosing hepatitis C with the hepatitis C antibody test
Learn about the hepatitis C antibody test, which is used to detect when someone has had the hepatitis C virus. What do the results mean? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 7, 2018 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Gilead fourth-quarter hepatitis C drug sales plummet, sees further slowdown
(Reuters) - Gilead Sciences Inc on Tuesday said fourth-quarter sales of its flagship hepatitis C drugs fell by more than half amid increased competition, and the company forecast a further slowdown for the current year. (Source: Reuters: Health)
Source: Reuters: Health - February 6, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

The Country ’s First Safe Injection Facility May Soon Open in Philadelphia. Here’s What You Need to Know
Last month, supervised injection facilities, also known as safe injection facilities (SIFs), were thrust back into the news when Philadelphia officials announced the city would likely become the first in the U.S. to adopt the controversial tactic for fighting opioid abuse. SIFs, which currently operate in Canada, Europe and Australia, offer drug users a place to use heroin and other narcotics under the supervision of medical professionals. (SIFs do not provide drugs, nor do their employees inject users directly.) Proponents say they can help curb overdose deaths, improve injection hygiene and expand access to addiction tre...
Source: TIME: Health - February 6, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthytime onetime Philadelphia Source Type: news

How viruses disarm the immune system
(McGill University) How do viruses that cause chronic infections, such as HIV or hepatitis c virus, manage to outsmart their hosts' immune systems? The answer to that question has long eluded scientists, but new research from McGill University has uncovered a molecular mechanism that may be a key piece of the puzzle. The discovery could provide new targets for treating a wide range of diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 5, 2018 Category: Infectious Diseases Source Type: news

Hatchet enzyme, enabler of sickness and of health, exposed by neutron beams
(Georgia Institute of Technology) A pioneering glimpse at an enzyme inside elusive cell membranes illuminates a player in cell health but also in hepatitis C and in Alzheimer's. With neutron beams, researchers open a portal into the hidden world of intramembrane proteins, which a third of the human genome is required to create. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 2, 2018 Category: Biology Source Type: news

Medical News Today: What is the relation between baby boomers and hepatitis C?
Learn about the relationship between baby boomers and hepatitis C, and why people born between 1945 and 1965 should be tested for the disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 1, 2018 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Engaging Active Drug Users about Hepatitis C: from Testing through Cure and Beyond
February 6, 2018 3:00-4:30pm ET.(National Viral Hepatitis Roundtable) (Source: PHPartners.org)
Source: PHPartners.org - January 30, 2018 Category: International Medicine & Public Health Source Type: news

NHS England sets out plans to be first in the world to eliminate hepatitis C
England could be the first country in the world to eliminate hepatitis C, under ambitious plans announced by the NHS. (Source: NHS Networks)
Source: NHS Networks - January 30, 2018 Category: UK Health Source Type: news

NHS bids to banish hepatitis C by 2025
The NHS is planning for England to be the first country in the world to eliminate Hepatitis C with health leaders saying they can eliminate the disease by 2025. (Source: the Mail online | Health)
Source: the Mail online | Health - January 29, 2018 Category: Consumer Health News Source Type: news

Medical News Today: HCV RNA PCR test: Qualitative and quantitative results
The HCV RNA PCR test is a blood test used to diagnose hepatitis C and measure the level of the hepatitis C virus in the bloodstream. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 26, 2018 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Medical News Today: What to eat if you have hepatitis C
Hepatitis C can damage the liver and lead to cirrhosis, or scarring of the liver. Damage to the liver may mean that a person needs to modify their diet. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 25, 2018 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Medical News Today: What is acute hepatitis C and is it serious?
Learn about acute hepatitis C, the form of the disease that occurs within 2 weeks to 6 months of exposure to the v írus. We look at symptoms and treatments. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 25, 2018 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Repurposed drug found to be effective against Zika virus
In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses. Writing in the current online issue of the journal Scientific Reports, researchers at University of California San Diego School of Medicine, with colleagues in Brazil and elsewhere, say their findings support further investigation of using the repurposed drug as a potential treatment for Zika-infected adults, including pregnant women. (Source: World Pharma News)
Source: World Pharma News - January 25, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Repurposed drug found to be effective against Zika virus
(University of California - San Diego) In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus -- and blocked transmission of the virus to mouse fetuses. Researchers at University of California San Diego School of Medicine, with colleagues in Brazil and elsewhere, say their findings support further investigation of using the repurposed drug as a potential treatment for Zika-infected adults, including pregnant women. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 25, 2018 Category: Infectious Diseases Source Type: news

Viral replication discovery could spur new broad-spectrum antivirals
(Morgridge Institute for Research) Scientists at the Morgridge Institute for Research have discovered a new Achilles heel in the replication process of positive-strand RNA viruses, a class responsible for health threats such as Zika, polio, chikungunya and hepatitis C. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 24, 2018 Category: Infectious Diseases Source Type: news

Hepatitis C Infection: Updated Information for Front Line Workers in Primary Care Settings
February 14, 2018 2:00-3:00pm ET. (Source: PHPartners.org)
Source: PHPartners.org - January 23, 2018 Category: International Medicine & Public Health Source Type: news

Co-managing HIV, Hepatitis C, and Opioid Abuse Co-managing HIV, Hepatitis C, and Opioid Abuse
Treating or even curing these infections isn't enough. Without treatment for opioid abuse, the patient will die.Medscape Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 23, 2018 Category: Consumer Health News Tags: Infectious Diseases Expert Column Source Type: news

The Linked Epidemics of Opioid Addiction and Hepatitis C
For February 2018,AJPH showcases articles on acute hepatitis C virus and opioid use, the effect of Medicaid expansions on early-stage cancer diagnoses, menu-labeling regulations for restaurants, and trends in illicit cigarette use in Brazil. Articles may require a subscription to view. (Source: PHPartners.org)
Source: PHPartners.org - January 23, 2018 Category: International Medicine & Public Health Source Type: news

Risks for Hepatitis B Reactivation with Newer Hep C Treatments Detailed
About a quarter of patients with chronic hepatitis B infection experience reactivation of the virus when they receive direct-acting antivirals (DAAs) for hepatitis C... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 22, 2018 Category: Primary Care Source Type: news

Treating Chronic Hepatitis C Infection in Primary Care Treating Chronic Hepatitis C Infection in Primary Care
New treatment guidelines aim to support primary care clinicians in the treatment of hepatitis C infection.Medscape HIV/AIDS (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 17, 2018 Category: Consumer Health News Tags: Infectious Diseases Commentary Source Type: news

Implementation Strategies and the Uptake of Hepatitis C Treatment in VA
February 1, 2018 12:00-1:00pm ET. (Source: HSR Information Central)
Source: HSR Information Central - January 17, 2018 Category: International Medicine & Public Health Source Type: news

Psoriasis Improved Following Hepatitis C Treatment
One man's psoriasis lesions cleared following treatment for chronic hepatitis C infection with direct-acting antivirals. The case report appears in the Annals of Internal... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 16, 2018 Category: Primary Care Source Type: news

Impact of the Opioid Epidemic on City and Local Health Departments Combatting HCV (Hepatitis C Virus) and Other Infectious Diseases
National Association of County and City Health Officials. 07/11/2017 This one-hour, six-minute presentation, from the 2017 National Association of County and City Health Officials (NACCHO) Annual Conference, discusses how city and local health departments are dealing with the increase of infectious disease cases because of the opioid epidemic, and the actionable steps they are taking for early diagnosis. Speakers'topics include the implementation of a new program for rapid hepatitis C testing in the local public health context, and the intersection of overdose opioid use disorder and hepatitis C virus in Pennsylvania. (Vid...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 11, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Public health-primary care testing has high uptake, doesn't identify hidden hepatitis C
(American Academy of Family Physicians) A strategy to test the general population for hepatitis B and C viruses in areas of high prevalence had high test uptake but did not detect hidden chronic hepatitis C infections. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 9, 2018 Category: International Medicine & Public Health Source Type: news

NPPA lens on five pharma companies for Hepatitis C drug overcharge
NPPA has sent show-cause notices to these companies alleging overcharging for the combination drug used to treat the potentially fatal Hepatitis C virus that harms the liver. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 8, 2018 Category: Pharmaceuticals Source Type: news

Study Backs Hepatitis C Treatment in Injection Drug Users
Use of sofosbuvir-velpatasvir to treat hepatitis C virus (HCV) infection in injection drug users usually leads to a sustained virologic response at 12 weeks... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 8, 2018 Category: Primary Care Source Type: news

From Retirement to the Front Lines of Hepatitis C Treatment From Retirement to the Front Lines of Hepatitis C Treatment
This doctor came out of retirement with the goal of treating every patient at high risk for hepatitis C he encounters. The problem is finding them.Kaiser Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 5, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Increase in Hepatitis C Infections Linked to Worsening Opioid Crisis
New CDC research suggests that the recent steep increase in cases of acute hepatitis C virus infection is associated with increases in opioid injection. (Source: PHPartners.org)
Source: PHPartners.org - January 3, 2018 Category: International Medicine & Public Health Source Type: news

Barriers to Hepatitis C Treatment in the Era of DAAs Barriers to Hepatitis C Treatment in the Era of DAAs
Direct-acting anti-virals are safe and highly effective treatments for hepatitis C virus. So why aren't they being prescribed more extensively?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 29, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

The prevalence of occupational health-related problems in dentistry: A review of the literature.
CONCLUSION:Occupational health-related problems are still prevalent in current dentistry practice, despite changes in equipment and surgery design. The reported prevalence of occupational related-health problems and other findings of investigative studies highlight the need for continuous professional education and a need to improve clinical practice aspects of dentistry curricula. (Source: Dental Technology Blog)
Source: Dental Technology Blog - December 26, 2017 Category: Dentistry Source Type: news

Opioid crisis trims U.S. life expectancy, boosts hepatitis C: CDC
CHICAGO (Reuters) - The opioid crisis is rippling through the U.S. healthcare system, causing a spike in rates of hepatitis C related to increased opioid injections and reducing overall life expectancy among Americans, which has fallen for the second year in a row, U.S. health officials said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - December 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Medical News Today: When to get tested for hepatitis C after exposure
Learn what the window period is for hepatitis C infection, and when someone should consider testing. We look at available tests and when symptoms appear. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 21, 2017 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

ParMedQuest invests in helparound, will co-market HIV, Hepatitis C management app
Healthcare management company PharMedQuest announced last week that it has made a strategic investment in helparound, an Israeli company which makes an app that supports and connects patients with chronic conditions. The companies have also made an agreement to co-market the mobile app, called ACE, to speciality pharmaceutical companies and patient hubs.   (Source: mobihealthnews)
Source: mobihealthnews - December 20, 2017 Category: Information Technology Source Type: news

PharMedQuest invests in helparound, will co-market HIV, Hepatitis C management platform
Correction: A previous version of this article misstated that ACE was the name of the mobile app. ACE is the name of PharMedQuest's customer relationship management platform and not the mobile app.   (Source: mobihealthnews)
Source: mobihealthnews - December 20, 2017 Category: Information Technology Source Type: news

Hepatitis C (HCV, Hep C)
Title: Hepatitis C (HCV, Hep C)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 12/19/2017 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - December 19, 2017 Category: Nutrition Source Type: news

Should uninfected patients accept hepatitis C-infected livers to reduce waiting time?
(Massachusetts General Hospital) A modeling study by Massachusetts General Hospital investigators finds that the availability of directly-acting antiviral drugs to treat hepatitis C virus infection could allow the transplantation of livers from HCV-positive donors into HCV-negative recipients without posing undue risk. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 19, 2017 Category: International Medicine & Public Health Source Type: news

MSF Challenges Gilead ’s Hepatitis C Patent Application in China
Press releaseMSF Challenges Gilead ’s Hepatitis C Patent Application in ChinaDecember 18, 2017The international medical humanitarian organization Doctors Without Borders/M édecins Sans Frontières (MSF) has filed a patent challenge in China to block Gilead’s patent application for the combination of two key oral hepatitis C medicines, sofosbuvir and velpatasvir. (Source: MSF News)
Source: MSF News - December 18, 2017 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news

Medical News Today: Hepatitis C outside the body and other virus facts
In this article, we take a look at how long the hepatitis C virus can survive outside the body, and how this impacts on transmission risks. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 17, 2017 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news